source
- Novartis halts ALS drug VHB937 after phase 2 trial fails to meet endpointsNovartis announced it is stopping development of its ALS candidate VHB937 after the phase 2 Astrals trial did not meet its primary or secondary endpoints. The study enrolled 251 patients with earl…
- Five major drugmakers cooperate with House investigation of Chinese military hospital trialsRep. John Moolenaar, a Republican from Michigan, announced that five large pharmaceutical companies are working with a congressional probe into clinical trials conducted at Chinese military hospita…